1. Home
  2. ELPC vs ALKS Comparison

ELPC vs ALKS Comparison

Compare ELPC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELPC
  • ALKS
  • Stock Information
  • Founded
  • ELPC 1954
  • ALKS 1987
  • Country
  • ELPC Brazil
  • ALKS Ireland
  • Employees
  • ELPC N/A
  • ALKS N/A
  • Industry
  • ELPC Electric Utilities: Central
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELPC Utilities
  • ALKS Health Care
  • Exchange
  • ELPC Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • ELPC 3.9B
  • ALKS 4.7B
  • IPO Year
  • ELPC N/A
  • ALKS 1991
  • Fundamental
  • Price
  • ELPC $5.25
  • ALKS $28.50
  • Analyst Decision
  • ELPC
  • ALKS Buy
  • Analyst Count
  • ELPC 0
  • ALKS 11
  • Target Price
  • ELPC N/A
  • ALKS $36.00
  • AVG Volume (30 Days)
  • ELPC 5.2K
  • ALKS 1.5M
  • Earning Date
  • ELPC 01-01-0001
  • ALKS 02-13-2025
  • Dividend Yield
  • ELPC 5.25%
  • ALKS N/A
  • EPS Growth
  • ELPC 43.89
  • ALKS 55.25
  • EPS
  • ELPC 0.19
  • ALKS 1.97
  • Revenue
  • ELPC $4,076,906,276.00
  • ALKS $1,505,121,000.00
  • Revenue This Year
  • ELPC N/A
  • ALKS N/A
  • Revenue Next Year
  • ELPC $8.16
  • ALKS N/A
  • P/E Ratio
  • ELPC $7.24
  • ALKS $14.60
  • Revenue Growth
  • ELPC 4.83
  • ALKS N/A
  • 52 Week Low
  • ELPC $5.04
  • ALKS $22.90
  • 52 Week High
  • ELPC $7.74
  • ALKS $32.88
  • Technical
  • Relative Strength Index (RSI)
  • ELPC 44.21
  • ALKS 41.99
  • Support Level
  • ELPC $5.04
  • ALKS $27.70
  • Resistance Level
  • ELPC $5.43
  • ALKS $29.36
  • Average True Range (ATR)
  • ELPC 0.10
  • ALKS 0.62
  • MACD
  • ELPC 0.01
  • ALKS -0.15
  • Stochastic Oscillator
  • ELPC 53.44
  • ALKS 35.87

About ELPC Companhia Paranaense de Energia (COPEL) (each representing four (4))

Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Holding and Services. Majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: